PPT-Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata

Author : tremblay | Published Date : 2023-08-30

Shoemaker T MacNeil A Balinandi S Campbell S Wamala J McMullan LK et al Reemerging Sudan Ebola Virus Disease in Uganda 2011 Emerg Infect Dis 201218914801483 httpsdoiorg103201eid1809111536

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 1 Figure 1. . . Sudan Ebola virus..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata: Transcript

Shoemaker T MacNeil A Balinandi S Campbell S Wamala J McMullan LK et al Reemerging Sudan Ebola Virus Disease in Uganda 2011 Emerg Infect Dis 201218914801483 httpsdoiorg103201eid1809111536. Figure 1 shows the locations of the variousPDS Centres and Stations and lists the mainfunctions of each of them (except the PACs,where only the instruments are listed).systematic re-use of those facil SEASES ANCROB Virologye virus family Filoviridae includes 3 genera: CuevavirusMarburgvirus, and Ebolavirus (EBOV). ere are 5 species that have been identied: Zaire, Bundibugyo, Sudan, R Fischer RJ, Judson SD, Miazgowicz K, Bushmaker T, Munster VJ. Ebola Virus Persistence in Semen Ex Vivo. Emerg Infect Dis. 2016;22(2):289-291. https://doi.org/10.3201/eid2202.151278. Wawina-Bokalanga T, Vanmechelen B, Lhermitte V, Martí-Carreras J, Vergote V, Koundouno F, et al. Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes. Emerg Infect Dis. 2021;27(1):76-84. https://doi.org/10.3201/eid2701.202177. Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, et al. Genetic Diversity and Distribution of Peromyscus-Borne Hantaviruses in North America. Emerg Infect Dis. 1999;5(1):75-86. https://doi.org/10.3201/eid0501.990109. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, et al. Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease. Emerg Infect Dis. 2014;20(10):1683-1690. https://doi.org/10.3201/eid2010.140430. Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT, Madoff LC, et al. Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis. 2016;22(2):295-297. https://doi.org/10.3201/eid2202.151416. Kirschner DE, Webb G. Resistance, Remission, and Qualitative Differences in HIV Chemotherapy. Emerg Infect Dis. 1997;3(3):273-283. https://doi.org/10.3201/eid0303.970303. Bozza FA, Moreira-Soto A, Rockstroh A, Fischer C, Nascimento AD, Calheiros AS, et al. Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil. Emerg Infect Dis. 2019;25(2):311-315. https://doi.org/10.3201/eid2502.180166. Haddock E, Feldmann F, Feldmann H. Effective Chemical Inactivation of Ebola Virus. Emerg Infect Dis. 2016;22(7):1292-1294. https://doi.org/10.3201/eid2207.160233. Keawcharoen J, van Riel D, van Amerongen G, Bestebroer TM, Beyer WE, van Lavieren R, et al. Wild Ducks as Long-Distance Vectors of Highly Pathogenic Avian Influenza Virus (H5N1). Emerg Infect Dis. 2008;14(4):600-607. https://doi.org/10.3201/eid1404.071016. Young DS, Kramer LD, Maffei JG, Dusek RJ, Backenson P, Mores CN, et al. Molecular Epidemiology of Eastern Equine Encephalitis Virus, New York. Emerg Infect Dis. 2008;14(3):454-460. https://doi.org/10.3201/eid1403.070816. AlNaji. . Overview. Ebola disease is the term for a group of deadly diseases in people caused by four ebolaviruses within the genus Ebolavirus. There are occasional Ebola disease outbreaks in people, occurring primarily on the African continent... Fernandez-Garcia M, Majumdar M, Kebe O, Fall AD, Kone M, Kande M, et al. Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015. Emerg Infect Dis. 2018;24(1):65-74. https://doi.org/10.3201/eid2401.171174.

Download Document

Here is the link to download the presentation.
"Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

North Clin Istanbul 2015218186An overview of Ebola virus diseaseD

Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,

PPT-Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata

Presentation Embed Code

Download Presentation

Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata: Transcript

North Clin Istanbul 2015218186An overview of Ebola virus diseaseD

Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,

Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,

Figure 1 Figure 1. Overall hantavirus phylogenetic tree based on analysis of

Figure 1 Figure 1. Viral loads for Ebola virus disease patients infected with Sudan virus

Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Figure 2 Figure 2. Zika virus and CHIKV antibody dynamics among samples from patients

Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival

Appendix Figure 4 Appendix Figure 4. Highly pathogenic avian influenza virus

Figure 1 Figure 1. . A) United States map showing locations of eastern equine encephalitis

Ebola Disease By Dr. Hussein

Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

PPT-Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata

Presentation Embed Code

Download Presentation

Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata: Transcript

North Clin Istanbul 2015218186An overview of Ebola virus diseaseD

Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,

Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,

Figure 1 Figure 1.&nbsp;Overall hantavirus phylogenetic tree based on analysis of

Figure 1 Figure 1. Viral loads for Ebola virus disease patients infected with Sudan virus

Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United

Figure 5 Figure 5.&nbsp;5a simulates combined drug treatment data reported for a patient

Figure 2 Figure 2. Zika virus and CHIKV antibody dynamics among samples from patients

Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival

Appendix Figure 4 Appendix Figure 4.&nbsp;Highly pathogenic avian influenza virus

Figure 1 Figure 1. . A) United States map showing locations of eastern equine encephalitis

Ebola Disease By Dr. Hussein

Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

Figure 1 Figure 1. Overall hantavirus phylogenetic tree based on analysis of

Figure 5 Figure 5. 5a simulates combined drug treatment data reported for a patient

Appendix Figure 4 Appendix Figure 4. Highly pathogenic avian influenza virus